KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Net Income towards Common Stockholders: 2010-2025

Historic Net Income towards Common Stockholders for Opko Health (OPK) over the last 16 years, with Sep 2025 value amounting to $21.6 million.

  • Opko Health's Net Income towards Common Stockholders fell 13.09% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$180.4 million, marking a year-over-year decrease of 34.89%. This contributed to the annual value of -$53.2 million for FY2024, which is 71.81% up from last year.
  • As of Q3 2025, Opko Health's Net Income towards Common Stockholders stood at $21.6 million, which was up 114.57% from -$148.4 million recorded in Q2 2025.
  • Opko Health's Net Income towards Common Stockholders' 5-year high stood at $31.1 million during Q1 2021, with a 5-year trough of -$148.4 million in Q2 2025.
  • Over the past 3 years, Opko Health's median Net Income towards Common Stockholders value was -$19.6 million (recorded in 2023), while the average stood at -$39.7 million.
  • Per our database at Business Quant, Opko Health's Net Income towards Common Stockholders surged by 152.75% in 2021 and then crashed by 1,340.62% in 2025.
  • Over the past 5 years, Opko Health's Net Income towards Common Stockholders (Quarterly) stood at -$73.3 million in 2021, then declined by 16.23% to -$85.2 million in 2022, then increased by 21.98% to -$66.5 million in 2023, then spiked by 121.12% to $14.0 million in 2024, then fell by 13.09% to $21.6 million in 2025.
  • Its Net Income towards Common Stockholders was $21.6 million in Q3 2025, compared to -$148.4 million in Q2 2025 and -$67.6 million in Q1 2025.